Merck
Merck & Co. is a global biopharmaceutical company based in New Jersey that discovers, develops, and markets medicines and vaccines to treat cancer, infectious diseases, autoimmune disorders, and other conditions. The company maintains a strong cancer portfolio anchored by an immuno-oncology therapy platform led by Keytruda and a growing vaccine business including Gardasil for human papillomavirus. Its research arm, Merck Research Laboratories, focuses on discovering and developing therapies for cancer and neurodegenerative diseases. Merck also markets animal health products. Through its science-driven approach, Merck aims to deliver innovative products and therapies that improve patient outcomes worldwide.
Top Sectors
Top Regions
https://crunchbase.com/organization/***
https://linkedin.com/company/***
https://signal.nfx.com/firms/***
Past deals in New Jersey
electroCore
Series B in 2017
electroCore is a commercial-stage medical device company focused on non-invasive vagus nerve stimulation (nVNS) therapies. Its gammaCore platform provides prescription-only nVNS treatments for acute migraine and episodic cluster headache in adults and for preventive management of cluster headache and migraine. The company offers gammaCore Sapphire, a rechargeable handheld device designed for multi-year use with monthly prescriptions. The platform aims to address neurology-related conditions by providing non-invasive neuromodulation alternatives, with FDA-cleared indications for several adult-use conditions and expanding use in adolescents.
electroCore
Series A in 2014
electroCore is a commercial-stage medical device company focused on non-invasive vagus nerve stimulation (nVNS) therapies. Its gammaCore platform provides prescription-only nVNS treatments for acute migraine and episodic cluster headache in adults and for preventive management of cluster headache and migraine. The company offers gammaCore Sapphire, a rechargeable handheld device designed for multi-year use with monthly prescriptions. The platform aims to address neurology-related conditions by providing non-invasive neuromodulation alternatives, with FDA-cleared indications for several adult-use conditions and expanding use in adolescents.
ImpactRx
Series E in 2010
ImpactRx, Inc. is a promotion research organization serving the pharmaceutical industry in the United States. The company specializes in tracking and evaluating the effects of pharmaceutical promotions on physicians' prescribing behaviors. Utilizing its proprietary technology, ImpactRx collects and processes data regarding physicians' perceptions and activities, enabling pharmaceutical companies to assess and predict the effectiveness of their sales and marketing initiatives. The organization offers a variety of syndicated and semi-custom products focused on brand management, market research, sales management, managed care marketing, and oncology sales and marketing. These services support pharmaceutical and biotech companies in making informed decisions. Founded in 2000, ImpactRx is headquartered in Mount Laurel, New Jersey.
ImpactRx
Series C in 2003
ImpactRx, Inc. is a promotion research organization serving the pharmaceutical industry in the United States. The company specializes in tracking and evaluating the effects of pharmaceutical promotions on physicians' prescribing behaviors. Utilizing its proprietary technology, ImpactRx collects and processes data regarding physicians' perceptions and activities, enabling pharmaceutical companies to assess and predict the effectiveness of their sales and marketing initiatives. The organization offers a variety of syndicated and semi-custom products focused on brand management, market research, sales management, managed care marketing, and oncology sales and marketing. These services support pharmaceutical and biotech companies in making informed decisions. Founded in 2000, ImpactRx is headquartered in Mount Laurel, New Jersey.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.